Timothy J Price Selected Research

Rectal Neoplasms (Rectal Cancer)

5/2017	Capecitabine in locally advanced anal cancer, do we need randomised evidence?
1/2016	Optimal therapy for resectable rectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy J Price Research Topics

Disease

55	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2004
38	Neoplasms (Cancer) 06/2022 - 09/2007
10	Neoplasm Metastasis (Metastasis) 12/2021 - 03/2008
7	Breast Neoplasms (Breast Cancer) 06/2021 - 12/2014
4	Stomach Neoplasms (Stomach Cancer) 12/2021 - 04/2012
3	Wounds and Injuries (Trauma) 04/2019 - 02/2016
3	Sarcoma (Soft Tissue Sarcoma) 11/2017 - 01/2014
3	Infections 05/2017 - 02/2004
3	Exanthema (Rash) 07/2014 - 07/2013
2	Disease Progression 01/2022 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 07/2018 - 02/2016
2	Liver Diseases (Liver Disease) 01/2018 - 09/2007
2	Rectal Neoplasms (Rectal Cancer) 05/2017 - 01/2016
2	Hyperammonemia 09/2010 - 09/2007
1	Fibrosis (Cirrhosis) 06/2022
1	Carcinoid Heart Disease 06/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Adenocarcinoma 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Triple Negative Breast Neoplasms 08/2019
1	Myocardial Infarction 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Shock 01/2019
1	Takotsubo Cardiomyopathy 01/2019
1	Gallbladder Neoplasms (Gallbladder Cancer) 08/2018
1	Carcinoid Tumor (Carcinoid) 05/2018
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

16	Cetuximab (Erbitux)FDA Link 12/2020 - 10/2008
12	Panitumumab (Vectibix)FDA Link 12/2020 - 07/2013
12	Monoclonal AntibodiesIBA 12/2020 - 10/2008
10	Bevacizumab (Avastin)FDA Link 01/2022 - 07/2010
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2011
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2011
8	ErbB Receptors (EGF Receptor)IBA 12/2020 - 10/2008
7	Capecitabine (Xeloda)FDA Link 01/2022 - 07/2010
7	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2022 - 02/2004
6	Biological ProductsIBA 01/2017 - 01/2010
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2013
5	Irinotecan (Camptosar)FDA LinkGeneric 12/2018 - 02/2013
5	Fluorouracil (Carac)FDA LinkGeneric 05/2017 - 02/2004
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2014
4	AntibodiesIBA 01/2021 - 07/2011
3	Hormones (Hormone)IBA 06/2022 - 06/2021
3	sotorasibIBA 01/2022 - 01/2020
3	Estrogens (Estrogen)FDA Link 06/2021 - 01/2016
3	Progesterone FDA LinkGeneric 06/2021 - 01/2016
3	Estrogen ReceptorsIBA 06/2021 - 09/2019
3	Growth Factor ReceptorsIBA 07/2013 - 07/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021 - 02/2013
2	Formaldehyde (Formol)FDA Link 01/2020 - 08/2014
2	ParaffinIBA 01/2020 - 08/2014
2	Annexin A5IBA 04/2019 - 02/2018
2	Propidium (Propidium Iodide)IBA 04/2019 - 02/2018
2	bacopaside IIIBA 07/2018 - 02/2018
2	Protein Isoforms (Isoforms)IBA 01/2017 - 01/2012
2	TensinsIBA 02/2014 - 06/2013
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2014 - 06/2013
2	AmmoniaIBA 09/2010 - 09/2007
2	YttriumIBA 08/2008 - 03/2008
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2022
1	AerosolsIBA 12/2021
1	Messenger RNA (mRNA)IBA 06/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2021
1	TriterpenesIBA 05/2021
1	SaponinsIBA 05/2021
1	ChromatinIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	trebananibIBA 01/2021
1	Keratins (Keratin)IBA 01/2021
1	MucinsIBA 01/2021
1	CateninsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 11/2019
1	human ERBB2 proteinIBA 09/2019
1	ginsenoside Rg3IBA 08/2019
1	MicroRNAs (MicroRNA)IBA 05/2019
1	3- (4,5- dimethylthiazol- 2- yl)- 5- (3- carboxymethoxyphenyl)- 2- (4- sulfophenyl)- 2H- tetrazoliumIBA 04/2019
1	omega-Chloroacetophenone (Mace)IBA 01/2019
1	NexusIBA 01/2019
1	CatecholaminesIBA 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 01/2019
1	NormetanephrineIBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	IgG Receptors (Fc gamma RI)IBA 11/2018
1	Peptide Receptors (Peptide Receptor)IBA 05/2018
1	Radioisotopes (Radionuclides)IBA 05/2018
1	Everolimus FDA Link 01/2018
1	atezolizumabIBA 01/2018

Therapy/Procedure

34	Drug Therapy (Chemotherapy) 01/2022 - 09/2007
33	Therapeutics 12/2020 - 09/2007
5	Radiotherapy 11/2017 - 03/2008
2	Adjuvant Chemotherapy 06/2021 - 01/2020
2	Microspheres (Microsphere) 08/2008 - 03/2008
1	Pancreaticoduodenectomy 08/2018